About us Contacts Interactions: 118 620
Drug search by name

Urofollitropin Intramuscular, Subcutaneous, Injection and Tumors

Result of checking the interaction of drug Urofollitropin Intramuscular, Subcutaneous, Injection and disease Tumors for safety when used together.

Check result:
Urofollitropin Intramuscular, Subcutaneous, Injection <> Tumors
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of follicle stimulating hormone is contraindicated in patients with sex hormone-dependent tumors of the reproductive tract and accessory organs (ovary, breast, uterus) and in patients with pituitary tumors. FSH is required for normal sex hormone production, which may be detrimental in these patients. Patients in later reproductive life have a greater predisposition to endometrial carcinoma.

References:
  • "Product Information. Gonal-F (follicle stimulating hormone)." Serono Laboratories Inc, Norwell, MA.
  • "Product Information. Follistim (follicle stimulating hormone)." Organon, West Orange, NJ.
Urofollitropin Intramuscular, Subcutaneous, Injection

Generic Name: urofollitropin

Brand Name: Bravelle, Metrodin, Fertinex

Synonyms: Urofollitropin